Skip to nav Skip to content

Oswald Avery Award

Facebook Twitter LinkedIn Email

The Oswald Avery Award for Early Achievement recognizes outstanding achievement in an area of infectious diseases by an IDSA member or fellow who is 45 or younger (on December 31 of the year preceding the IDWeek at which the award is given). The award is based on overall achievement, not usually a single study.


Nominees for the Oswald Avery Award for Early Achievement must be 45 or younger. Please take a moment to review the nomination application and ensure that an NIH biosketch is available to upload as a part of the nominations package.

2022 Winner: Nadine Rouphael, MD, FIDSA


Rouphael_Nadine_headshot (1).BMPNadine Rouphael, MD, FIDSA, is a physician-scientist who has made key contributions to research on the prevention and treatment of COVID-19 and on vaccines for influenza. Dr. Rouphael has led or served as (or is currently leading or serving as) a principal investigator on more than 50 clinical trials and has served as an investigator on more than 150 clinical trials. She is currently a principal investigator on 7 NIH-funded grants and a principal investigator, co-investigator, or contract principal investigator on 15 other grants.

Dr. Rouphael is a professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine, a senior physician at Emory Healthcare, and executive director of the Emory Vaccine Center Hope Clinic. The clinical arm of the Emory Vaccine Center, the Hope Clinic directs on-site vaccine clinical trials and provides translation of pre-clinical vaccine research into clinical trials in humans.

During the Adaptative COVID-19 Treatment Trials, which led to the licensure of remdesivir and the FDA approval of baricitinib, Dr. Rouphael led a team of researchers that enrolled more patients than any other site. Dr. Rouphael was Emory’s lead investigator for the phase 1 Moderna mRNA vaccine trial and the joint first author of an article in the New England Journal of Medicine. Under her leadership and working with the Grady and Emory Children Center, Emory enrolled 700 participants in the phase 3 Moderna trial. Dr. Rouphael also played a key role in the analysis of immune responses in COVID-19 patients and in defining signatures of disease severity.

Outside of COVID-19, Dr. Rouphael led a landmark study on a microneedle influenza vaccine patch and led translational research on innate immunity and systems biology using vaccines to probe the immune system. The first-in-human study showed that the microneedle influenza vaccine patch is safe, immunogenic, and preferred by patients to needles. Dr. Rouphael’s translational research was one of the first studies to show an association between antibiotic use and the decreased immunogenicity of the influenza vaccine and correlates of protection.

Currently, Dr. Rouphael is the international chair of the Sanofi clinical trial studying the safety and efficacy of adjuvanted protein COVID-19 vaccines, the international co-chair of the COVAIL clinical trial to determine optimal timing and vaccine components for the fourth COVID-19 vaccine dose, and the national chair for the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) observational study, which is evaluating the clinical, virologic, and immunologic aspects of severe COVID-19.

Also, Dr. Rouphael is the Emory principal investigator for the NIH-funded Vaccine Treatment and Evaluation Unit and the Clinical Core principal investigator for the NIH-funded Human Immunology Project Consortium. She co-directs the Emory Stimulating Access to Research in Residency R38 Program and is the associate director of the Emory T32 vaccinology grant.

Dr. Rouphael has published more than 170 peer-reviewed research articles, including 35 articles in NEJM, Lancet, Nature, and Science. Her work has led to more than 10,000 citations. IDSA is pleased to recognize her with the 2022 Oswald Avery Award for Early Achievement.


Past Oswald Avery Award Winners

2021 Michail Lionakis, MD, ScD, FIDSA
2020 Sallie R. Permar, MD, PhD
2019 Nasia Safdar, MD, MS, PhD, FIDSA, FSHEA
2018 Susanna Naggie, MD, MHS, FIDSA
2017 William J. Steinbach, MD
2016 Susan S. Huang, MD, MPH, FIDSA, FSHEA
2015 Eric R. Houpt, MD, FIDSA
2014 Sarah E. Cosgrove, MD, MS, FIDSA, FSHEA and Rochelle P. Walensky, MD, MPH, FIDSA
2013 Cesar A. Arias, MD, MSc, PhD, FIDSA
2012 Dan A. Barouch, MD, PhD
2011 Umesh Parashar, MBBS, MPH
2010 Eleftherios Mylonakis, MD, PhD, FIDSA 
2009 Jean-Laurent Casanova, MD, PHD
2008 Vance G. Fowler, Jr., MD, MHS 
2007 Pablo C. Okhuysen, MD, FIDSA
2006 Cynthia G. Whitney, MD, MPH
2005 James E. Crowe, MD
2004 B. Brett Finlay, PhD
2003 Joseph Heitman, MD, PhD
2002 Matthew K. Waldor, MD, PhD
2001 David A. Relman, MD
2000 Michael S. Donnenberg, MD
1999 William A. Petri, Jr., MD, PhD
1998 Joseph W. St. Geme, III, MD
1997 Samuel I. Miller, MD
1996 David D. Ho, MD
1995 Michael Osterholm, PhD, MPH
1994 Mark Klempner, MD
1993 Claire Broome, MD
1992 Martin Blaser, MD
1991 Marcus Horwitz, M.D.
1990 Jerrold Ellner, MD
1989 Henry Murray, MD
1988 Walter Stamm, MD
1987 John Gallin, MD
1986 Charles Dinarello, MD
1985 Dennis Kasper, MD
1984 Adel Mahmoud, MD, PhD
1983 Anthony Fauci, MD
1982 George Miller, PhD
1981 Gerald Keusch, MD
1980 Robert Purcell, MD
1979 Stanley Falkow, PhD
1978 King Holmes, MD, PhD
1977 Lowell Glasgow, MD, MS
1976 Sheldon Wolff, MD
1975 Kenneth Warren, MD
1974 Malcolm Artenstein, MD and Emil Gotschilch, MD
1973 Frank Austen, MD
1972 Zanvil Cohn, MD
1971 Jonathan Uhr, MD
1970 Hans Mueller-Eberhard, MD, DMSc
1969 Robert Chancock, MD
1968 Robert Good, MD, PhD



This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.